Burzynski Clinic

The Burzynski Clinic is a medical clinic in Texas, United States founded in 1976 and offering unproven cancer treatment. It is best known for the controversial "antineoplaston therapy", a chemotherapy using compounds it calls antineoplastons, devised by the clinic's founder Stanislaw Burzynski in the 1970s. There is no accepted scientific evidence of benefit from antineoplaston combinations for various diseases.

The clinic has been the focus of criticism primarily due to the way its antineoplaston therapy is promoted, the costs for people with cancer participating in "trials" of antineoplastons, problems with the way these trials are run, and legal cases brought as a result of the sale of the therapy without state board approval.

Burzynski was born on January 23, 1943 in Lublin, Poland. He graduated from the Medical Academy in Lublin. The following year he earned a Ph.D. in biochemistry.

Burzynski moved to the United States in 1970, working at Baylor College until 1977, when he established the Burzynski Research Laboratory where he administered antineoplaston therapy, initially to 21 patients but then more widely as "experimental" treatment. This opened him up to "charges of unethical conduct and to the suspicion he had become a merchant of false hope", which led to several instances of media controversy.

Burzynski founded the Burzynski Research Institute in 1984. His scientific papers have caused academic controversy, with reviewers disputing the design of the trials and scientific validity of the published results.

In February 2017 following lengthy hearings the Texas Medical Board recommended Burzynski's medical license be revoked, with the revocation suspended, and a fine of $360,000 for billing irregularities and other violations.

Antineoplaston is a name coined by Burzynski for a group of peptides, peptide derivatives, and mixtures that he uses as an alternative cancer treatment. The word is derived from neoplasm.

...
Wikipedia